Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MMP1 | P03956 | 1/20 | 0.49 |
| ▸ | MMP3 | P08254 | 1/20 | 0.49 |
| ▸ | MMP7 | P09237 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.49 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 3/20 | 0.38 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146966 | 0.96 | KDM4E (0.48) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL13947098 | 0.81 | KDM4E (0.50) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL25332706 | 0.81 | KDM4E (0.55) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL3796160 | 0.79 | KDM4E (0.48) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL356631 | 0.79 | KDM4E (0.48) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL15287180 | 0.79 | KDM4E (0.48) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL6253172 | 0.78 | CYP1A2 (0.41) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL1109612 | 0.78 | KDM4E (0.47) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL14640707 | 0.77 | KDM4E (0.45) | KDM4ELMNAMMP1MMP3MMP7 | |
| SCHEMBL23879799 | 0.76 | KDM4E (0.50) | KDM4ELMNAMMP1MMP3MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638661-A | Iron maltol-quercetin eutectic crystal and preparation method thereof | 金陵药业股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119638662-A | Iron maltol-oxalic acid eutectic crystal and preparation method thereof | 金陵药业股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119371388-A | Synthesis method of maltol iron crystal form II | 珠海保税区丽珠合成制药有限公司 | 2025-01-28 | — | — | CN | claimed |
| EP-3666247-B1 | DIVIDED CURABLE COMPOSITION | MITSUI CHEMICALS INC (JP) | 2024-12-18 | — | — | EP | claimed |
| CN-119102106-A | Active antibacterial self-cleaning fabric and preparation method thereof | 南通大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118978503-A | Iron maltol crystal form and preparation method thereof | 重庆君药生物医药有限公司 | 2024-11-19 | — | — | CN | claimed |
| EP-2938608-B1 | SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 | SANFORD BURNHAM MED RES INST (US) | 2021-08-04 | — | — | EP | claimed |
| EP-2712614-B1 | SOLVATING SYSTEM AND SEALANT FOR MEDICAL USE | MEDTRONIC XOMED INC (US) | 2017-11-29 | — | — | EP | claimed |
| EP-2029232-B1 | Antibacterial extracellular polysaccharide solvating system | MEDTRONIC XOMED INC (US) | 2017-09-20 | — | — | EP | claimed |
| US-9539233-B2 | Gallium formulation for the treatment and prevention of infectious diseases | ARIDIS PHARMACEUTICALS INC. (US) | 2017-01-10 | — | — | US | claimed |
| US-20040089101-A1 | Copper nanocrystals and methods of producing same | WAYNE STATE UNIVERSITY | 2004-05-13 | — | — | US | claimed |
| US-20020193363-A1 | Use of nitric oxide scavengers to modulate inflammation and matrix metalloproteinase activity | ANORMED INC. (CA) | 2002-12-19 | — | — | US | claimed |
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | ANORMED INC. (CA) | 2002-04-25 | — | — | US | claimed |
| US-20020045611-A1 | Pharmaceutical compositions comprising metal complexes | ABRAMS MICHAEL J (US) | 2002-04-18 | — | — | US | claimed |
| EP-1163247-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2001-12-19 | — | — | EP | claimed |
| US-6284752-B1 | ATTENUATION FO NITROGEN OXIDE CONCENTRATION OF A DISEASE | ANORMED INC. (CA) | 2001-09-04 | — | — | US | claimed |
| WO-2000056743-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | ANORMED INC. (CA) | 2000-09-28 | — | — | WO | claimed |
| US-5824673-A | COMPLEXES FOR MEDIATION OF LOCALIZED HIGH CONCENTRATIONS OF NITRIC OXIDE IN BODIES | JOHNSON MATTHEY PUBLIC LIMTED COMPANY (GB) | 1998-10-20 | — | — | US | claimed |
| EP-0714294-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | Johnson Matthey PLC (GB) | 1996-06-05 | — | — | EP | claimed |
| WO-1995005814-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1995-03-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049190-A1 | Pharmaceutical compositions comprising metal complexes | CFD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, F12 | KDM4E 2866/4885LMNA 645/4885MMP1 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.